Mark Vanderland
Internal Medicine · Philadelphia, PANPI 1427610237
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 96.2% of the total across 129 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 31 manufacturers, the largest accounting for just 16.0% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2024 at $1,840 and has fallen 66.9% since, to $610 in 2025. Among internal medicine clinicians in PA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 129 payments — averaging $48.31 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$997
- Boston Scientific$779
- Abiomed$651
- Heartflow, Inc.$497
- ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$491
- Novartis$409
- plus $2K from 25 others
What the payments were for
- Food & beverage$5,99896%
- Education$2344%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 13 | $997 |
| Boston Scientific | 10 | $779 |
| Abiomed | 12 | $651 |
| Heartflow, Inc. | 4 | $497 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 9 | $491 |
| Novartis | 16 | $409 |
| Medtronic | 6 | $290 |
| Johnson & Johnson | 5 | $263 |
| Amgen | 5 | $247 |
| Pfizer | 10 | $229 |
| E.r. Squibb & Sons, L.L.C. | 9 | $189 |
| Cvrx, Inc. | 1 | $153 |
| Paratek Pharmaceuticals, Inc. | 1 | $115 |
| Lexicon Pharmaceuticals, Inc. | 1 | $108 |
| Portola Pharmaceuticals, LLC | 1 | $97 |
| Daxor Corporation | 2 | $81 |
| Lantheus Medical Imaging, Inc. | 2 | $78 |
| Stryker | 1 | $74 |
| Shockwave Medical, Inc | 2 | $65 |
| Sanofi | 2 | $61 |
| Boehringer Ingelheim | 3 | $48 |
| Abbott | 2 | $48 |
| Kiniksa Pharmaceuticals International, PLC | 2 | $44 |
| BD | 1 | $37 |
| Chiesi USA, Inc. | 2 | $34 |
| Kiniksa Pharmaceuticals, Ltd. | 2 | $33 |
| Edwards Lifesciences | 1 | $30 |
| Penumbra, Inc. | 1 | $25 |
| Scpharmaceuticals Inc. | 1 | $23 |
| Terumo Medical Corporation | 1 | $21 |
| Bristol Myers Squibb | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$6,232 in reported general payments places this provider in the 90th percentile of 5,705 internal medicine providers in Pennsylvania.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| ClopidogrelClopidogrel Bisulfate | 17 | $442 |
| Atorvastatin Calcium | 21 | $327 |
| Losartan Potassium | 19 | $321 |
| Carvedilol | 15 | $147 |
Paid to pharmacies, not to this prescriber.
Other internal medicine in Philadelphia
- Jonathan EpsteinPhiladelphia$13.1M
- Pitamber DevgonPhiladelphia$7.5M
- Daniel RaderPhiladelphia$1.7M
- David GoldmannPhiladelphia$525K
- Eyob FeyssaPhiladelphia$328K
- Emil AbramianPhiladelphia$199K
- Michael KnightPhiladelphia$178K
- James BlakePhiladelphia$164K
- Gina SimonciniPhiladelphia$158K
- James LewisPhiladelphia$106K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.